| Vol. 7.47 – 10 December, 2021 |
| |
|
|
| Researchers developed an organoid assembly approach starting with cells from the three primary germ layers—enteric neuroglial, mesenchymal, and epithelial precursors—that were derived separately from human pluripotent stem cell. [Cell Stem Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists developed an advanced three-dimensional in vitro intestinal model to test absorption in a more reliable manner, by better mimicking the native environment. [Journal of Controlled Release] |
|
|
|
| Investigators evaluated the in vitro effect of Manuka honey and its combination with 5-Fluorouracil, on the morphological and physical parameters of colonspheres enriched with cancer stem-like cells deriving from HCT-116 colon adenocarcinoma cell line and on the apoptosis rate. [Food Chemistry] |
|
|
|
| Scientists characterized that Lactobacillus plantarum activated the farnesoid X receptor – fibroblast growth factor 15 signaling in intestinal epithelial cells and hence promoted DNA-damage repair. [Journal of Cellular Physiology] |
|
|
|
| Researchers investigated the underlying mechanism of psychosocial stress in an inflammatory bowel disease mouse model pertaining to macrophage autophagy. [Cell Death Discovery] |
|
|
|
| Knockout of killin in human colorectal cells led to a dramatic decrease in p53-mediated G1 arrest upon DNA damage. [Cell Cycle] |
|
|
|
| Scientists analyzed the effect of xanthohumol on a primary colorectal adenocarcinoma cell line, HT29, on cell viability, inflammatory and antioxidant gene expression, and metabolism. [International Journal of Food Sciences and Nutrition] |
|
|
|
| The expression level of relative proteins in mTOR pathway was detected by western blot assay to investigate the mechanism of Qingjie Fuzheng granule effect on colorectal cancer cells. [Evidence-Based Complementary and Alternative Medicine] |
|
|
|
| Researchers clarified the role of hydroxysafflor yellow A in inhibiting colorectal cancer in vitro and the underlying mechanisms. [Bioengineered] |
| |
|
|
|
| Scentists present the state of the art on the most recently identified pathogenic mechanisms of this serious inflammatory bowel disease-related complication, focusing on possible targets of antifibrotic therapies, management strategies, and factors that might predict fibrosis progression or response to treatment. [Nature Reviews Gastroenterology & Hepatology] |
|
|
|
|
| Celularity Inc. announced the US FDA has cleared its Investigational New Drug application for the use of CYNK-101 in combination with standard chemotherapy, trastuzumab and pembrolizumab in patients with first-line locally advanced unresectable or metastatic HER2/neu positive gastric or gastroesophageal junction adenocarcinoma. [Celularity, Inc. (GlobenewsWire, Inc.)] |
|
|
|
|
| January 16 – 20, 2022 Banff, Alberta, Canada |
|
|
|
|
|
| Princess Margaret Cancer Centre – Toronto, Ontario, Canada |
|
|
|
| Technical University of Denmark – Lyngby, Denmark |
|
|
|
| Lund University – Malmö, Sweden |
|
|
|
| KU Leuven – Leuven, Belgium |
|
|
|
| The University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
|